Association of p53 polymorphisms and colorectal cancer: Modulation of risk and progression

E. Mammano, C. Belluco, M. Bonafé, F. Olivieri, E. Mugianesi, C. Barbi, M. Mishto, M. Cosci, C. Franceschi, M. Lise, D. Nitti

Research output: Contribution to journalArticlepeer-review


Objectives: p53 Gene variants BstUI RFLP at codon 72 in exon 4, 16 bp tandem repeat in intron 3 and MspI RFLP in intron 6, which code for two functionally different protein isoforms, have been shown to modulate susceptibility to different types of human neoplasms. Methods: p53 genotype was assessed in 90 CRC patients, 321 age-matched controls and 322 centenarians. Results: The p53 codon 72 arginine, the p53 16 bp deletion, and the MspI RFLP were significantly more frequent in CRC patients in comparison to the controls and to the centenarians (odd ratio 1.44 and 1.93). In the CRC group, the BstUI RFLP polymorphism was the more frequent combination (62.2%), and it was significantly associated with highly infiltrating (p <0.01), poorly differentiated (p <0.01), and metastatic (p <0.05) tumours. Our findings indicate that the p53 codon 72 polymorphisms are associated with a higher risk of CRC and are associated with more advanced and undifferentiated tumours.

Original languageEnglish
Pages (from-to)415-419
Number of pages5
JournalEuropean Journal of Surgical Oncology
Issue number4
Publication statusPublished - Apr 2009


  • Cancer risk
  • Centenarians
  • Colorectal cancer
  • p53
  • Polymorphism

ASJC Scopus subject areas

  • Oncology
  • Surgery


Dive into the research topics of 'Association of p53 polymorphisms and colorectal cancer: Modulation of risk and progression'. Together they form a unique fingerprint.

Cite this